StefanEisenRichterMD
Pulmonology • Los Angeles, CACritical Care Medicine, Pleural Disease
Clinical Associate, Medicine, Tufts Medical Center
Are you Dr. Richter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
"# 37-131"
Los Angeles, CA 90095Phone+1 310-825-5615
Summary
- Dr. Stefan Richter, MD is a pulmonologist in Los Angeles, California. He is currently licensed to practice medicine in California and Massachusetts. He is a Clinical Associate at Tufts Medical Center.
Education & Training
University of Michigan Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2014 - 2025
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 4 citationsRisk factors for development of aminoglycoside resistance among gram-negative rodsStefan Richter, Loren G. Miller, Jack Needleman, Daniel Z. Uslan, Douglas S. Bell
American Journal of Health-System Pharmacy. 2019-10-30 - 18 citationsRisk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods.Stefan Richter, Loren G. Miller, Jack Needleman, Daniel Z. Uslan, Douglas S. Bell
Open Forum Infectious Diseases. 2019-01-23 - 23 citationsRisk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.Stefan Richter, Loren G. Miller, Daniel Z. Uslan, Douglas S. Bell, Karol E. Watson
Journal of Clinical Microbiology. 2018-08-27
Press Mentions
For Two COVID-19 Patients, Life and Death Rests on ‘El Tubo’February 19th, 2021- An Electron Transfer Competent Structural Ensemble of Membrane-Bound Cytochrome P450 1A1 and Cytochrome P450 OxidoreductaseJanuary 8th, 2021
RASPD+: Fast Protein-Ligand Binding Free Energy Prediction Using Simplified Physicochemical FeaturesDecember 17th, 2020
